1. What incentives do pharmaceutical companies have to undertake R&D in medicines for treating AIDS? Malaria? Erectile dysfunction? What can policymakers do about this?
2. Does it matter if development aid just boosts government consumption in poor African economies? Why or why not?
3. If it is good institutions rather than good policies that matter, what implications does this have for aid agencies?